The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life

Last updated: November 9, 2021
Sponsor: Eskisehir Osmangazi University
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Covid-19

Treatment

N/A

Clinical Study ID

NCT04824469
EkisehirOsmangaziU
  • Ages > 18
  • All Genders

Study Summary

2019 coronavirus disease (Covid-19) is a virus that emerged in Wuhan, China in late 2019, spread all over the world in a short time and causes severe acute respiratory syndrome and pneumonia. The World Health Organization classified the COVID-19 outbreak as an "international public health emergency" on January 30 and declared a global epidemic (pandemic) on March 11, 2020, due to the rapid spread of the virus all over the world. speed in the number of cases and deaths. Covidien-19 first cases were reported in Turkey on 10 March 2020 and the number of cases has risen steadily.

The total number of COVID-19 cases worldwide on 31.01.2021; It was reported to be 101,917,147 and the total number of deaths was 2,205,515 (https://covid19.who.int/).

Considering that the number of cases is constantly increasing, it is obvious that hospitals will not meet the entire epidemic burden. During this period, home care has emerged as an alternative way to effectively alleviate the epidemic burden. Home healthcare during the COVID-19 pandemic; Four roles have stood out: home diagnosis, follow-up, treatment, and care.

Protective measures for home isolation of Covid-19 patients are the current method used to prevent the spread of cases. Possible or definite cases that do not have an indication for hospitalization, have a mild clinic and do not accompany severe chronic disease that may lead to a severe course of covid-19 are followed at home until their symptoms improve. In addition, patients who are hospitalized and meet discharge criteria can complete their recovery processes at home. Isolation is terminated on the 14th day at the earliest following the improvement of symptoms in patients who are followed at home. Reducing the contact of people, isolating certain and suspicious cases and effective use of personal protective equipment play an important role in combating the epidemic. It is thought that the training that COVID-19 cases to be followed up and treated at home will be effective in drug compliance, symptom management and quality of life will be effective in the management of the disease.

1251 / 5000 Çeviri sonuçları The universe of the research will be composed of people who apply to Zonguldak Atatürk State Hospital Emergency Service and Covid-19 Polyclinics. . The sample of the study, who accepted to participate in the study, was diagnosed with Covid-19 with U07.3 ICD code according to the results of PCR (Polymerase Chain Reaction) test and Thorax CT (Thorax CT), and was recommended to be followed up and treated at home by the Zonguldak Public Health Department It is planned to create individuals who meet the criteria.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Over the age of 18,
  • Does not have a communication problem that prevents participation in research oreducation, such as inability to understand / speak Turkish,
  • Being literate,
  • Residing in Zonguldak province, applying to hospitals in the province and diagnosedwith Covid-19 according to PCR (Polymerase Chain Reaction) test and Thorax CT (Thoraxcomputed tomography) results by the radiation teams and deemed appropriate for homefollow-up by the Zonguldak Public Health Directorate,
  • Having active Internet access and actively using a computer / tablet or smartphone,
  • Patients who agree to participate in the study

Exclusion

Exclusion Criteria:

  • No internet connection at home or on the phone,
  • Do not know how to use internet and computers,
  • Having a communication problem that prevents participation in research or education,such as inability to understand / speak Turkish, Patients who were previouslydiagnosed with Covid-19 and treated at home or in hospital,
  • With severe insufficiency (Heart failure, Kidney failure, Immune system failure)
  • Illiterate individuals will not be included in the study.

Study Design

Total Participants: 128
Study Start date:
December 15, 2021
Estimated Completion Date:
December 31, 2022

Study Description

G power analysis program was used to determine the sample size. The research will be conducted in two groups, an intervention and a control group. With professional support in calculating the sample size of the study, the sample size calculated at a 5% margin of error and a 95% confidence interval was found to be 128. However, against the possibility of sample losses during the follow-up process, the individual diagnosed with Covid-19 will be added to the number of samples by adding 20% (13 participants will be added for each group. 77 interventions in total, 77 controls) will be included in the study. Participants who meet the inclusion criteria and agree to participate in the study will be randomly assigned to the intervention and control groups.

DATA COLLECTION TOOLS

  • Patient information form

  • Memorial Symptom Rating Scale

  • Covid-19 Symptom Assessment Inventory

  • Morisky Adaptation Scale (Muö)

  • World Health Organization Quality of Life Inventory Short Form Turkish Version

  • E-Health literacy scale

  • Opinion Form Regarding the Web Based Training Program

  • DISCERN Guide (Expert Opinions)

  • Website Content Evaluation Form (Expert Opinions)